30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

eXoZymes Inc (EXOZ)

Track

Over the last 90 days, eXoZymes Inc. has seen a net insider selling of $15,424.2. The Chief Scientific Officer, Korman Tyler Paz, made two sell transactions totaling $15,424.2. The stock has experienced an 8.2% price increase over the past 90 days. No recent earnings reports are available.
Stock chart
Ticker: EXOZ Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Korman Tyler Paz
Chief Scientific Officer
1 sale — total 7,894 USD
Sale 9 Apr 2026
Value US$3,740,800.53 | Price 340.00 | Shares 53,978
Sale 8 Apr 2026
Value US$1,209,795.22 | Price 173.13 | Shares 82,649
Buy 2 Jul 2025
Value US$10,628.80 | Price 10.22 | Shares 1,040
Buy 17 Jan 2025
Value US$19,048.26 | Price 10.78 | Shares 1,767
Buy 16 Jan 2025
Value US$1,297.12 | Price 10.72 | Shares 121
Buy 15 Nov 2024
Value US$22,022.40 | Price 11.10 | Shares 1,984
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-10 2026-04-09 S Sale
Korman Tyler Paz

Chief Scientific Officer

Officer
53,978 +47.8%
340.00
US$3,740,801 		53,978 +47.8% 340.00 US$3,740,801
2026-04-10 2026-04-08 S Sale
Korman Tyler Paz

Chief Scientific Officer

Officer
82,649 +29.6%
173.13
US$1,209,795 		82,649 +29.6% 173.13 US$1,209,795
2025-07-02 2025-07-02 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
69,364 +42.2%
387.25
US$3,444,848 		69,364 +42.2% 387.25 US$3,444,848
2025-01-21 2025-01-17 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
1,767 +83.9%
10.78
US$19,048 		1,767 +83.9% 10.78 US$19,048
2025-01-21 2025-01-16 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
121 +6.1%
10.72
US$1,297 		121 +6.1% 10.72 US$1,297
2024-11-19 2024-11-15 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
1,984 +inf%
11.10
US$22,022 		1,984 +inf% 11.10 US$22,022
Explore more

More insider trading research around eXoZymes Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America